BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT03967743 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2026-05-01 3. primary completion date: 2025-06-01 → 2024-03-11 4. enrollment: 150 → 43 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical